PF-06438179 (Infliximab-Pfizer)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06438179 (Infliximab-Pfizer), covering 2017-09-11 to 2017-09-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). [Phase 3]